ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Clesrovimab (MK-1654) in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease (MK-1654-007)

ClinicalTrials.gov ID: NCT04938830

Public ClinicalTrials.gov record NCT04938830. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 10:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Partially Blinded, Palivizumab- Controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of MK-1654 in Infants and Children at Increased Risk for Severe RSV Disease

Study identification

NCT ID
NCT04938830
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
1,003 participants

Conditions and interventions

Conditions

Interventions

  • Clesrovimab Biological
  • Palivizumab Biological
  • Placebo Biological

Biological

Eligibility (public fields only)

Age range
Up to 1 Year
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 29, 2021
Primary completion
Apr 27, 2025
Completion
Jul 31, 2025
Last update posted
May 7, 2026

2021 – 2025

United States locations

U.S. sites
29
U.S. states
17
U.S. cities
25
Facility City State ZIP Site status
Miller Children's & Women's Hospital Long Beach ( Site 0001) Long Beach California 90806
Children's Hospital of Orange County ( Site 0047) Orange California 92868
Children's Hospital Colorado ( Site 0011) Aurora Colorado 80045
Children's National Medical Center ( Site 0020) Washington D.C. District of Columbia 20010
Orlando Health - Arnold Palmer Hospital-Orlando Health-Arnold Palmer Hospital Pulmonary and Sleep M ( Site 0022) Orlando Florida 32806
Nemours Children's Health, Lake Nona Medical City ( Site 0032) Orlando Florida 32827
University of South Florida-Department of Pediatrics ( Site 0045) Tampa Florida 33606
Morehouse School Of Medicine ( Site 0049) Atlanta Georgia 30310
Clinical Research Prime ( Site 0046) Idaho Falls Idaho 83404
University of Kentucky HealthCare - Turfland ( Site 0044) Lexington Kentucky 40536
Our Lady of the Lake Children's Hospital ( Site 0031) Baton Rouge Louisiana 70809
Tulane University School of Medicine ( Site 0010) New Orleans Louisiana 70112
M Health Fairview University of Minnesota Masonic Children's Hospital, West Bank-Peds Research ( Site 0037) Minneapolis Minnesota 55454
Rutgers University-Pediatric Clinical Research Center ( Site 0007) New Brunswick New Jersey 08901
NYU Langone Hospital - Long Island-Pediatrics ( Site 0028) Mineola New York 11501
University of Rochester Medical Center ( Site 0017) Rochester New York 14642
The University of North Carolina at Chapel Hill ( Site 0035) Chapel Hill North Carolina 27514
Duke University ( Site 0021) Durham North Carolina 27710
Dayton Children's Hospital ( Site 0053) Dayton Ohio 45449
Tribe Clinical Research, LLC ( Site 0002) Greenville South Carolina 29607
Driscoll Children's Hospital ( Site 0025) Corpus Christi Texas 78411
DHR Health Institute for Research and Development ( Site 0029) Edinburg Texas 78539
Christus Children's-Clinical Research Center ( Site 0038) San Antonio Texas 78207
University Hospital-Pediatrics ( Site 0019) San Antonio Texas 78229
Road Runner Research, Ltd ( Site 0052) San Antonio Texas 78249
Intermountain - Primary Children's Hospital ( Site 0026) Salt Lake City Utah 84113
Multicare Rockwood Main Clinic-Rockwood Pediatrics ( Site 0004) Spokane Washington 99202
Providence Sacred Heart Medical Center & Children's Hospital ( Site 0030) Spokane Washington 99204
MultiCare Health System-Baker Center ( Site 0036) Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 117 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04938830, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 7, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04938830 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →